Prophylactic use of OKT3 in cardiac transplantation.
Konertz
W
W
Kerckhoff-Klinik, Thorax- und Kardiovaskularchirurgie, Bad Nauheim, West Germany.
Weyand
M
M
Friedl
A
A
D000328:Adult; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood; D005260:Female; D016027:Heart Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D008875:Middle Aged; D016853:Muromonab-CD3; D009206:Myocardium / Q000473:pathology; D011183:Postoperative Complications / Q000473:pathology / Q000517:prevention & control
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D003404:Creatinine